Skip to main content
. 2016 Jan 14;101(4):365–370. doi: 10.1136/archdischild-2015-309522

Figure 2.

Figure 2

Relative risk of hypothalamic–pituitary–adrenal axis suppression: oral prednisolone and inhaled corticosteroids.17–19